Fw: MAPS Events / Including Jan. 12th internet audio with Albert Hofmann

Preston Peet ptpeet at nyc.rr.com
Wed Jan 12 00:44:51 EST 2005



----- Original Message ----- 
From: <rick at maps.org>
To: <maps-news at maps.org>
Sent: Tuesday, January 11, 2005 3:38 PM
Subject: MAPS Events / Including Jan. 12th internet audio with Albert 
Hofmann


> MAPS MEMBERS AND FRIENDS,
>
> MAPS has major new opportunities and challenges now that the FDA has
> approved the MAPS-sponsored study of the use of MDMA-assisted
> psychotherapy in subjects with anxiety associated with advanced-stage
> cancer, to be conducted by Dr. John Halpern, Harvard Medical School,
> McLean Hospital. 2005 looks to be an incredible year.
>
> We're writing you now to mention three upcoming events that may be of
> interest and to which all MAPS members are invited. The first is scheduled
> for tomorrow (January 12) and is an internet radio broadcast with Albert
> Hofmann, the Swiss chemist who created LSD and first synthesized
> psilocybin, on the occasion of his 99th birthday(which is today, January
> 11.)  The second event is  scheduled for January 26 in Park City, Utah, at
> the Sundance Film Festival. The third event is a MAPS-sponsored conference
> in Israel on March 24, 2005.
>
>
> 1) MAPS-SPONSORED INTERNET AUDIO BROADCAST WITH ALBERT HOFMANN, WEDNESDAY
> JANUARY 12, 2005 AT NOON EST, AND SEVERAL PSYCHEDELIC RESEARCHERS
>
>
> Join us Wednesday at 12 noon EST for a live internet audio broadcast of
> our celebration of Albert Hofmann's 99th birthday as Dr. Rick Doblin,
> president of MAPS and our panel of prominent scientists speak to Albert
> live in Switzerland about the renewal of psychedelic research and their
> work.
>
> Present during the conference call with Dr. Hofmann will be:
> Rick Doblin, Ph.D., President of MAPS.
> * Dr. Michael Mithoefer, MD. Principal Investigator, MAPS sponsored MDMA 
> PTSD study
> * Dr. John Halpern, MD. (Harvard), Principal Investigator, MAPS sponsored 
> MDMA Cancer Anxiety study
> * Dr. Andrew Sewell, MD. (Harvard), Principal Investigator, MAPS sponsored 
> LSD cluster headache study
> * Dr. Charles Grob, MD (Harbor-UCLA), Principal Investigator, Heffter 
> Institute sponsored Psilocybin Cancer Anxiety study
>
> The MAPS conference call starts at 12 noon EST (USA). It is being
> broadcast from multiple servers in mp3 format in multiple streams suitable
> for broadband and 56k modem uers.
>
> For more information, see: http://www.maps.org/conferences/ah99/
>
> 2) JANUARY 26, 2005 SUNDANCE FILM FESTIVAL: MAPS LECTURES AND PREVIEW OF 
> THE
> TRAILER FOR THE MOVIE, ENTHEOGEN: AWAKENING THE GOD WITHIN, BY CRITICAL
> MASS PRODUCTIONS
>
> The trailer for the movie, Entheogen: Awakening the God Within, produced
> by Critical Mass Productions, directed by Rod Mann, which focuses in part
> on MAPS-sponsored psychedelic research, will be shown at a party at the
> Sundance Film Festival. Speakers at the party will include Dr. John
> Halpern (MAPS' MDMA/cancer anxiety study), Dr. Charles Grob
> (Heffter-sponsored psilocybin/cancer anxiety study), and Rick Doblin,
> Ph.D. The party will be held at the club Suede Wednesday evening, January
> 26 and all MAPS members and friends are invited to attend. If you are
> considering attending, please contact Valerie Mojeiko, MAPS staff person,
> at valerie at maps.org. See the listing for Jan. 26 on the MAPS conference
> page at http://www.maps.org/conferences/index.html for more information
> and links to the trailer.
>
>
> 3) MARCH 24, 2005 MAPS-SPONSORED CONFERENCE IN ISRAEL.
>
> As part of MAPS' efforts to sponsor a pilot study in Israel into the use
> of MDMA-assisted psychotherapy in subjects with war and terrorism-related
> posttraumatic stress disorder (PTSD), MAPS is sponsoring a one-day
> conference in Israel on Thursday, March 24, 2005, in association with the
> Israeli Ministry of Health, the Israeli Anti-Drug Authority, and the
> Israeli  Society of Addiction Medicine.  MAPS is inviting all MAPS members
> and friends to attend and may also organize a 6-day tour of Israel,
> scheduled around the conference. If you are interested in attending, or
> would like more information, please contact Valerie Mojeiko, MAPS staff
> person, at valerie at maps.org.
>
> Speakers at the conference include:
>
> * Rick Doblin,Ph.D. President of MAPS.
> * Dr. Michael Mithoefer, MD. Principal Investigator, MAPS sponsored MDMA 
> PTSD study
> * Jose Carlos Bouso, Ph.D. candidate, Principal Investigator, proposd MAPS 
> sponsored MDMA PTSD study  in Spain
> * June May Ruse, Ph.D., director of MAPS' MDMA Treatment Manual Project
> * Dr. Raphael Mechoulam, Hebrew University, Marijuana/PTSD Study in Israel
> * Dr. John Halpern, MD. (Harvard), Principal Investigator, MAPS sponsored 
> MDMA Cancer Anxiety study
> * Dr. Charles Grob, MD (Harbor-UCLA), Principal Investigator, Heffter 
> Institute sponsored Psilocybin Cancer Anxiety study
> * Valerie Mojeiko, MAPS' ibogaine outcome study
>
>
> best wishes for a promising new year,
>
> Rick Doblin, Ph.D.
> MAPS
>
> 




More information about the Ibogaine mailing list